Rukhmi Bhat

  • 567 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My clincial interests are in bleeding and clotting disorders in children as well as non malignant blood disorders in children. My research interests are in risk-based optimization of treatment in pediatric thrombosis. My research focus within pediatric thrombosis is in neonates with thrombotic complications as well as developing venous thromboembolism risk assessment models in pediatrics.

Certifications and Licenses

Pediatric Hematology-Oncology

Training Experience

1997Internship, Grant Medical College/University of Bombay, India
2000Residency, King Edward Memorial Hospital, India
2006Residency, State University of New York at Brooklyn
2009Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)

Education/Academic qualification

MS, Northwestern University

… → 2009

MD, SUNY - Brooklyn

… → 2006

MD, King Edward Memorial Hospital India

… → 2000

Research interests

  • Hematology
  • Thrombosis/Fibrinolysis

Fingerprint Dive into the research topics where Rukhmi Bhat is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Anticoagulation in preterm and term neonates: Why are they special?

Bhat, R. & Monagle, P., Mar 2020, In : Thrombosis research. 187, p. 113-121 9 p.

Research output: Contribution to journalArticle

  • Fatigue in children and adolescents with immune thrombocytopenia

    Grace, R. F., Klaassen, R. J., Shimano, K. A., Lambert, M. P., Grimes, A., Bussel, J. B., Breakey, V. R., Pastore, Y. D., Black, V., Overholt, K., Bhat, R., Forbes, P. W. & Neunert, C., Jan 1 2020, (Accepted/In press) In : British Journal of Haematology.

    Research output: Contribution to journalArticle

  • 1 Scopus citations
  • Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

    EINSTEIN-Jr Phase 3 Investigators, Jan 2020, In : The Lancet Haematology. 7, 1, p. e18-e27

    Research output: Contribution to journalArticle

  • 9 Scopus citations